All posts by Eric Budd

Important Info for our Bladder Cancer patients from the American Urological Society

Original Release

Dear AUA Member:

Last month, we shared a message regarding Merck’s anticipated TICE BCG supply constraints due to an increasing global demand for the product.

To minimize disruption to patient care, Merck (the sole supplier of BCG to the United States) announced an immediate change to their TICE BCG distribution model, and in January, ceased all drop shipments and began allocating TICE BCG exclusively to wholesalers and distributors based on product supply and historical purchasing patterns. Wholesalers and distributors in turn, began utilizing the same allocation model to fulfill customer orders directly; therefore, please contact your wholesaler should you have any questions about your allotment.


UroLift Community Health Talk

The UroLift System flyer cover

Benign prostatic hyperplasia (BPH), formerly known as prostatism, is a common urological condition caused by the non-cancerous enlargement of the prostate gland in aging men.

As the prostate enlarges, it can squeeze down on the urethra. This can cause men to have trouble urinating, frequent need to urinate, urgency or other BPH symptoms. Risk factors for developing BPH include increasing age and a family history of BPH.

If you or a loved one are experiencing some of the challenges listed above, there are many options for treatment, one of which is discussed in the flyer with this post.


Snip City 2019

Snip City 2019

March Madness is almost here and we have an ideal reason for you to get out of work and watch the games – Snip City 2019!

Perfectly time your vasectomy with Urology of Central Pennsylvania to enjoy the tournament. This minor procedure is performed by experienced physicians in our office. Patients will be in and out for this procedure, just in time for March Madness.


UCPA introduces Cutting Edge Prostate Biopsy

Cutting Edge Prostate Biopsy

Urology of Central Pennsylvania introduces Cutting Edge Prostate Biopsy with 3D MRI/Ultrasound Fusion Technology

Targeted MRI/Ultrasound Fusion biopsy is the latest technology available in the detection and management of prostate cancer and Urology of Central PA is proud to offer this new standard of care. Using the revolutionary Artemis 3D imaging and navigation system, our physicians are now able to better identify and more accurately biopsy suspicious prostate cancer areas.


Prostate Cancer Awareness is Year-Round Issue

While we recognized Prostate Cancer Awareness Month in September, awareness-building for the disease is important year-round.

We reserved this clip of WITF’s Scott LaMar interviewing Kristine Warner from the PA Prostate Cancer Coalition and prostate cancer survivor, Mike Rotz, to share with you now. This interview is designed to enlighten people about some issues surrounding prostate cancer that may not normally be discussed. We hope it is a conversation starter for you with your friends, family and loved ones.